Markus Hengstschläger Selected Research

high density lipoprotein receptors

3/2019	Loss of SR-BI Down-Regulates MITF and Suppresses Extracellular Vesicle Release in Human Melanoma.
1/2018	Malignant Phenotypes in Metastatic Melanoma are Governed by SR-BI and its Association with Glycosylation and STAT5 Activation.
8/2015	The HDL receptor SR-BI is associated with human prostate cancer progression and plays a possible role in establishing androgen independence.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Markus Hengstschläger Research Topics

Disease

27	Neoplasms (Cancer) 01/2023 - 12/2003
20	Tuberous Sclerosis (Bourneville's Disease) 11/2023 - 01/2003
6	Melanoma (Melanoma, Malignant) 01/2022 - 11/2016
5	Inborn Genetic Diseases (Disease, Hereditary) 09/2011 - 11/2005
4	Granuloma 02/2024 - 01/2017
3	Sarcoidosis (Schaumann Disease) 02/2024 - 01/2017
3	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 10/2019
3	Carcinogenesis 01/2023 - 09/2011
3	Hypoxia (Hypoxemia) 01/2017 - 12/2012
3	Autoimmune Diseases (Autoimmune Disease) 08/2013 - 10/2008
3	Breast Neoplasms (Breast Cancer) 08/2013 - 03/2004
3	Neuroblastoma 08/2008 - 05/2006
2	Colitis 11/2023 - 10/2019
2	Colonic Neoplasms (Colon Cancer) 01/2023 - 01/2018
2	Birth Weight (Birth Weights) 01/2021 - 05/2012
2	Leukemia 01/2018 - 07/2009
2	Inflammation (Inflammations) 11/2017 - 10/2008
2	Choriocarcinoma 08/2017 - 01/2016
2	Type 2 Diabetes Mellitus (MODY) 02/2015 - 07/2012
2	Carcinoma (Carcinomatosis) 11/2012 - 09/2006
2	Hamartoma 07/2009 - 09/2005
2	Alzheimer Disease (Alzheimer's Disease) 09/2006 - 11/2005
2	Down Syndrome (Down's Syndrome) 11/2005 - 04/2004
1	Progeria (Hutchinson Gilford Syndrome) 04/2024
1	Fibrosis (Cirrhosis) 10/2023
1	Iron Deficiencies 01/2023
1	Pre-Eclampsia (Preeclampsia) 01/2023
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2023
1	Aneuploidy (Aneuploid) 01/2022
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022
1	Adenocarcinoma 01/2022
1	Lymphoma (Lymphomas) 01/2018
1	Neoplasm Metastasis (Metastasis) 01/2018
1	Disease Progression 01/2017

Drug/Important Bio-Agent (IBA)

18	Proteins (Proteins, Gene)FDA Link 01/2023 - 04/2004
10	trans-sodium crocetinate (crocetin)IBA 12/2021 - 01/2003
9	Tuberous Sclerosis Complex 2 ProteinIBA 08/2013 - 12/2003
8	Mechanistic Target of Rapamycin Complex 1IBA 11/2023 - 09/2010
7	TOR Serine-Threonine KinasesIBA 10/2023 - 10/2008
5	Tuberous Sclerosis Complex 1 ProteinIBA 07/2009 - 12/2003
4	CholesterolIBA 02/2024 - 08/2015
4	Phosphotransferases (Kinase)IBA 01/2017 - 09/2008
4	Sirolimus (Rapamycin)FDA Link 05/2016 - 07/2009
3	LipidsIBA 02/2024 - 09/2008
3	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 12/2003
3	HDL LipoproteinsIBA 01/2022 - 01/2018
3	CytokinesIBA 10/2019 - 09/2015
3	high density lipoprotein receptorsIBA 03/2019 - 08/2015
3	EnzymesIBA 11/2017 - 04/2004
3	Small Interfering RNA (siRNA)IBA 05/2016 - 03/2012
3	Cyclin-Dependent Kinase Inhibitor p27IBA 08/2013 - 09/2006
2	Everolimus FDA Link 10/2023 - 09/2015
2	ProteomeIBA 01/2022 - 02/2015
2	Transcription Factors (Transcription Factor)IBA 01/2021 - 01/2014
2	Mechanistic Target of Rapamycin Complex 2IBA 10/2019 - 09/2010
2	Scavenger Receptors (Scavenger Receptor)IBA 03/2019 - 01/2018
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2017 - 09/2008
2	MercuryIBA 01/2016 - 10/2010
2	LipopolysaccharidesIBA 09/2015 - 04/2011
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2014 - 12/2012
2	Protein Kinases (Protein Kinase)IBA 02/2013 - 06/2009
1	MicroRNAs (MicroRNA)IBA 04/2024
1	Reducing AgentsIBA 02/2024
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 02/2024
1	PolyaminesIBA 11/2023
1	SpermidineIBA 11/2023
1	SpermineIBA 11/2023
1	gamma Catenin (Plakoglobin)IBA 10/2023
1	Connexin 43 (Connexin43)IBA 10/2023
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2023
1	MK 2206IBA 01/2023
1	AZD 6244IBA 01/2023
1	torinIBA 01/2023
1	InterferonsIBA 01/2023
1	Tyrosine (L-Tyrosine)FDA Link 01/2023
1	Therapeutic UsesIBA 01/2023
1	CollagenIBA 01/2023
1	IronIBA 01/2023
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2022
1	VemurafenibIBA 01/2022
1	dichlorobis(azomycin)platinum IIIBA 01/2022
1	Apoptosis Regulatory ProteinsIBA 12/2021
1	MAP-kinase-activated kinase 2IBA 12/2021
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2021
1	Environmental Pollutants (Pollutants, Environmental)IBA 01/2021
1	OsteopontinIBA 10/2019
1	Aurora KinasesIBA 01/2018
1	STAT5 Transcription FactorIBA 01/2018
1	Cell Adhesion MoleculesIBA 01/2018
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 12/2017
1	InterleukinsIBA 11/2017
1	RNA (Ribonucleic Acid)IBA 08/2017
1	Methionine (L-Methionine)FDA Link 08/2017
1	Leucine (L-Leucine)FDA Link 08/2017
1	Matrix Metalloproteinases (MMPs)IBA 01/2017
1	Mitogen-Activated Protein KinasesIBA 01/2017

Therapy/Procedure

12	Therapeutics 02/2024 - 06/2009
3	Transplantation 01/2023 - 10/2008
2	Drug Therapy (Chemotherapy) 01/2022 - 01/2018
1	Injections 01/2022